On September 16th, RemeGen fell more than 8%, BeiGene fell nearly 4%, genscript bio, tigermed, and wuxi bio fell more than 1%.
港股生物医药股回调 荣昌生物跌超8%
Hong Kong biomedical stocks pull back, and Remegen drops more than 8%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.